Absci (ABSI) EBIT Margin (2020 - 2026)
Absci's (ABSI) quarterly EBIT Margin came in at 14346.98% in Q1 2026, down 1199507.0% year-on-year from N/an in Q1 2025, and down 200.43% quarter-over-quarter from 4775.54% in Q4 2025.
Absci (ABSI) EBIT Margin (2020 - 2026) Analysis & Trends
Absci has disclosed EBIT Margin across 7 years of filings, most recently posting 14346.98% for Q1 2026.
- EBIT Margin for Q1 2026 came in at 14346.98%, down 1199507.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 6722.98% (down 437368.0% YoY), and the FY2025 annual result was 4297.04%, down 189545.0% from the prior year.
- EBIT Margin came in at 14346.98% for Q1 2026 at Absci, down from 4775.54% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 1180.54% in Q3 2022 to a low of 17289.34% in Q4 2022.
- The 5-year median for EBIT Margin is 3132.12% (2023), against an average of 5208.47%.
- Across the five-year window, EBIT Margin sank 1342248 bps in 2022 and jumped 997011 bps in 2023, its largest moves.
- Absci's EBIT Margin stood at 17289.34% in 2022, then jumped by 58 bps to 7319.23% in 2023, then surged by 39 bps to 4477.29% in 2024, then decreased by 7 bps to 4775.54% in 2025, then sank by 200 bps to 14346.98% in 2026.
- The last three EBIT Margin figures came in at 14346.98% (Q1 2026), 4775.54% (Q4 2025), and 7977.25% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | -14,346.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14,346.98% |
| Dec 31, 2025 | -4,775.54% |
| Sep 30, 2025 | -7,977.25% |
| Jun 30, 2025 | -5,293.93% |
| Mar 31, 2025 | -2,351.91% |
| Dec 31, 2024 | -4,477.29% |
| Sep 30, 2024 | -1,698.71% |
| Jun 30, 2024 | -2,104.02% |
| Mar 31, 2024 | -2,616.70% |
| Dec 31, 2023 | -7,319.23% |
| Sep 30, 2023 | -3,132.12% |
| Jun 30, 2023 | -1,276.74% |
| Mar 31, 2023 | -1,929.47% |
| Dec 31, 2022 | -17,289.34% |
| Sep 30, 2022 | -1,180.54% |
| Jun 30, 2022 | -2,882.93% |
| Mar 31, 2022 | -7,891.23% |
| Dec 31, 2021 | -3,866.86% |
| Sep 30, 2021 | -1,521.01% |
| Jun 30, 2021 | -12,273.53% |